 | Trevi Therapeutics, Inc. | |||
| NGM : TRVI || Location: United States | ||||
$2.54-0.11 (-4.15%) |
0.17 M | 2.45 - 2.68 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.898 M |
| March 28, 2024 | 1.044 M |
| March 15, 2024 | 1.070 M |
| Feb. 29, 2024 | 1.238 M |
| Feb. 15, 2024 | 1.192 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.09 | -0.08 | 14.44% |
| 09/30/2023 | -0.09 | -0.08 | 14.44% |
| 06/30/2023 | -0.09 | -0.07 | 19.26% |
| 03/31/2023 | -0.07 | -0.06 | 19.79% |
| 12/31/2022 | -0.11 | -0.06 | 43.98% |
TRVI Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 68.960M | Shares Float | 39.234M |
| Short Float | 0.898M | Market Cap | 182.74M |
| Institution ownership | 80.77% | Insider ownership | 1.280% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.29 | Forward EPS | -0.45 |